Standpoint Research Downgrades Bed Bath & Beyond (BBBY) to Hold
- Tech stocks push S&P 500 to record close, buoy Nasdaq
- U.S. Calls for Pause of J&J (JNJ) Vaccine After Clotting Cases, Including One Death
- Coinbase (COIN) direct listing IPO reference price set at $250
- Oil rises after robust China data but J&J vaccine pause weighs
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Standpoint Research analyst Ronnie Moas downgraded Bed Bath & Beyond (NASDAQ: BBBY) from Buy to Hold.
Shares of Bed Bath & Beyond closed at $36.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bed Bath & Beyond (BBBY) call put ratio 1 call to 1.5 puts into quarter release and outlook
- Piper Sandler Downgrades Luminex (LMNX) to Neutral
- Itau BBA Downgrades Credicorp (BAP) to Market Perform